medicines


Trading health through IPR, patents
Trade agreements between countries have a perceivable impact on access to medicines as a result of changes in patent and other national laws in different countries.
Canada blinks in face of US/Pharma pressure
The cool reasoning of the Canadian Supreme Court does not acknowledge or reference “external” pressures or the Eli Lilly v. Canada ISDS case. However, courts do not decide cases in a vacuum. This case seems to have been decided in a pressure cooker.
No RCEP Campaign: Stop trading away human rights
The 'No RCEP' campaign urges governments to consider the adverse impact of the mega free trade agreement
More trouble for Canada-EU trade deal, as drug changes delay implementation
Goal of implementing most of CETA this summer slips farther from reach.
Civil society interventions on the RCEP
In the recent “RCEP 18th Round of Talks,” members of civil society organizations and social movements presented their positions vis-à-vis the RCEP.
MSF response on the India-EFTA free trade agreement negotiations in Liechtenstein this week
Through this deal, Swiss pharmaceutical corporations are working to erode India’s ability to produce and supply generic medicines for people across the developing world.
Why RCEP is the problem, not the solution
RCEP negotiations have been highly conspiratorial and undemocratic, with all 18 rounds of trade discussions held in secret and no reports shared with the public
Women’s intervention at the RCEP TNC 18th round stakeholders’ meeting in Philippines
The RCEP will only further marginalize women
Protests mark RCEP Manila rounds
#NoRCEP week of actions at the 18th TNC Meeting of the Regional Comprehensive Economic Partnership
Reject RCEP and reject unjust trade deals
Trade Justice Pilipinas expresses its opposition to the Regional Comprehensive Economic Partnership agreement or RCEP